The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy.

CONCLUSION: EDIC can be recommended as a useful tool to predict lymphopenia and inferior clinical outcomes, and it should be minimized below 4 Gy.
PMID: 32182504 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 12, 2020 Category: Radiology Authors: Xu C, Jin JY, Zhang M, Liu A, Wang J, Mohan R, Kong FS, Lin SH Tags: Radiother Oncol Source Type: research